Cargando…
Fighting Multidrug Resistance with Ruthenium–Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition
[Image: see text] The search for more effective and selective drugs to overcome cancer multidrug resistance is urgent. As such, a new series of ruthenium-cyclopentadienyl (“RuCp”) compounds with the general formula [Ru(η(5)-C(5)H(4)R)(4,4′-R′-2,2′-bipy)(PPh(3))] were prepared and fully characterized...
Autores principales: | Teixeira, Ricardo G., Salaroglio, Iris C., Oliveira, Nuno F. B., Sequeira, João G. N., Fontrodona, Xavier, Romero, Isabel, Machuqueiro, Miguel, Tomaz, Ana Isabel, Garcia, M. Helena, Riganti, Chiara, Valente, Andreia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614197/ https://www.ncbi.nlm.nih.gov/pubmed/37616241 http://dx.doi.org/10.1021/acs.jmedchem.3c01120 |
Ejemplares similares
-
Ruthenium(II)–Cyclopentadienyl-Derived Complexes as New Emerging Anti-Colorectal Cancer Drugs
por: Teixeira-Guedes, Catarina, et al.
Publicado: (2022) -
New Ruthenium-Cyclopentadienyl Complexes Affect Colorectal Cancer Hallmarks Showing High Therapeutic Potential
por: Brás, Ana Rita, et al.
Publicado: (2023) -
Ruthenium carboranyl complexes with 2,2′-bipyridine derivatives for potential bimodal therapy application
por: Teixeira, Ricardo G., et al.
Publicado: (2020) -
Antioxidant Activity of Ruthenium Cyclopentadienyl Complexes Bearing Succinimidato and Phthalimidato Ligands
por: Juszczak, Michał, et al.
Publicado: (2022) -
Design and Anticancer Properties of New Water-Soluble Ruthenium–Cyclopentadienyl Complexes
por: Morais, Tânia S., et al.
Publicado: (2022)